Search the Newsreel

PomDoctor Ltd (POM) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of PomDoctor Ltd (POM) including its support, resistance, indicators, and moving averages. It details various technical indicator values and their directions (e.g., MACD, RSI, KDJ, ATR, CCI, Williams %R, TRIX, StochRSI) and moving average statuses. The analysis concludes …

Amdocs Ltd (DOX) Institutional Confidence

Amdocs Ltd (DOX) has an institutional shareholding score of 10.00, placing it first in the Software & IT Services industry. Institutional shareholding stands at 98.79%, a 6.44% decrease quarter-over-quarter. Richard Pzena is the largest institutional shareholder, holding 13.50M shares, representing 11.79% of shares outstanding.

PomDoctor Ltd (POM) Dividends & Stock Splits: Historical Payouts and Event Timeline

The article provides a financial overview of PomDoctor Ltd (POM), detailing its dividend history and stock split events. It indicates that the company has not distributed any dividends in the past five years and lists a significant merger event on May 28, 2026, with …

PomDoctor Ltd (POM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article details PomDoctor Ltd's (POM) revenue breakdown by business segment for FY2024 and FY2023, with data updated on April 6. The largest revenue contributor is Prescription drugs, followed by Over the counter (OTC) medicines, Traditional Chinese Medicine (TCM), and other categories. Regional revenue …

Amdocs Ltd (NASDAQ:DOX): A Value Stock with a 4% Dividend and Single-Digit P/E

Amdocs Ltd (NASDAQ:DOX) is presented as an attractive value stock with a 4% dividend and a single-digit P/E ratio, trading significantly below its industry average. Despite a recent 20% price drop, the company demonstrates strong profitability with high ROIC and operating margins, along with …

POM|PomDoctor Ltd|Price:0.710|Chg%:-0.009

This article provides a detailed profile of PomDoctor Ltd (POM), an online medical services platform specializing in chronic disease management and pharmaceutical services. It covers the company's background, business scope, key financial data, and market performance, including executive leadership, IPO details, and top revenue …

Amdocs Ltd (DOX) Shareholder Structure: Major Shareholders & Institutional Holdings

This article provides a detailed breakdown of Amdocs Ltd (DOX) shareholder structure, including major institutional holders and their proportional ownership. It lists top investment firms like Pzena Investment Management and Fidelity Management & Research Company, along with shareholder types and changes in institutional holdings …

Bank of Nova Scotia Has $14.44 Million Holdings in Amdocs Limited $DOX

Amdocs Ltd (DOX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Amdocs Ltd (DOX), categorizing its revenue by business segments and geographic regions. For FY2026Q1, managed services arrangements contributed 64.53% ($745.90M) of the revenue, with North America being the dominant region, accounting for 66.15% ($764.70M) of the …

Amdocs: AI Fears Created This Shareholder Yield Monster

Amdocs (DOX) has seen its share price decline due to AI-driven fears, despite being deeply integrated into major mobile network operators' critical operations. The company is actively adapting to the AI era by launching new products and acquiring AI capabilities, while also exiting low-margin …

DOX|Amdocs Ltd|Price:52.100|Chg%:+1.250

Amdocs Ltd (DOX) exhibits healthy fundamentals and high growth potential, with its valuation considered fairly valued within the Software & IT Services industry. The stock has a high institutional ownership, and analysts have largely rated it as a Buy. Despite recent sideways trading, Amdocs …

Form 144 AMDOCS LTD For: 23 July By Investing.com

This article briefly reports on the filing of Form 144 for Amdocs Ltd (DOX) on July 23, 2026. Form 144 is filed with the SEC to announce the intent to sell restricted or control securities. The article provides the company's stock symbol and a …

Amdocs (DOX) affiliate plans Rule 144 sale of 107,577 ordinary shares

An affiliate of Amdocs Limited (DOX) has filed a Rule 144 notice to sell 107,577 ordinary shares, with an aggregate market value of $5,510,093.94, through Oppenheimer & Co. Inc. on Nasdaq. These shares originated from restricted stock units (RSUs) that vested between November 2020 …

Amdocs (DOX) Could Be 38% Undervalued As Sales Weakness Clouds The Outlook

Recent analysis suggests that Amdocs (DOX) may be 38% undervalued despite declining annual sales and earnings growth compared to peers. The company's financials feature strong recurring revenue streams, a high renewal rate for managed services, and a substantial 12-month backlog, supporting a fair value …

How Investors Are Reacting To Amdocs (DOX) Slowing Sales Despite Rising Earnings And Low Valuation

Amdocs (DOX) is facing investor caution due to a 3.6% sales decline over the past two years and a forecast of only 3.2% growth, despite an 8.1% annual increase in EPS and a low forward P/E of 6.8x. This hesitancy stems from concerns that …

Amdocs Ltd (DOX) Stock Price, Trades & News

This GuruFocus article provides a comprehensive overview of Amdocs Ltd (DOX), a provider of software and services to communications companies. It details the company's financial strength, growth, profitability, valuation metrics, and dividend information. The report also highlights recent news, analyst estimates, key statistics, and …

Amdocs Ltd Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh

This article provides financial information for Amdocs Ltd Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh (D2OX34) on the BMFBOVESPA exchange, specifically highlighting its price to earnings forward. The market is currently closed, with no trades observed. The data is presented through the TradingView …

Q1 Earnings Highs And Lows: Amdocs (NASDAQ:DOX) Vs The Rest Of The IT Services & Other Tech Stocks

Why Is Amdocs (DOX) Down 9.5% Since Last Earnings Report?

McDonald’s Is Trading Near a 52-Week Low While Generating $7 Billion in Free Cash Flow Every Year

Some Investors May Be Willing To Look Past Amdocs' (NASDAQ:DOX) Soft Earnings

5 Insightful Analyst Questions From Amdocs’s Q1 Earnings Call

What Amdocs (DOX)'s Mixed Q2 2026 Results and aOS Traction Update Mean For Shareholders

Amdocs (DOX) Tops Q2 Earnings and Revenue Estimates

Earnings call transcript: Amdocs Q2 2026 beats expectations, stock dips

McDonald’s Beat Q1 2026 Estimates. Here’s What a $430 Target Means for MCD Stock

McDonald’s Q1 2026: Strongest Revenue Growth in Eight Quarters

McDonald’s Q4 2025 Earnings: Revenue Hits $7B With 10% Growth

Amdocs Ltd (NASDAQ:DOX) Presents a Compelling Value Investment Case

Why Is Amdocs (DOX) Down 5.9% Since Last Earnings Report?

Amdocs (DOX) Is Down 10.1% After 2026 Guidance Update And Announcing CEO Transition

McDonald’s Stock Outlook: A Path to 20% Returns

Pomdoctor (POM) Losses Persist as Price-to-Sales Premium Tests Bullish Scaling Narrative

McDonald's Aktie - Prognose bis 2030